1. Committee for Medicinal Products for Human Use (CHMP). CPMP/EWP/205/95/Rev.3. Guideline on the Evaluation of Anticancer Medicinal Products in Man. 14 Dec 2005. London, England. [accessed 25.03.2007].
2. Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics. 2007 May. Rockville (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. [accessed 14.05.2007].
3. National Cancer Institute, U.S. Department of Health and Human Services. Dictionary of Cancer Terms. [accessed 24.03.2007].
4. .
5. Do post-approval phase III trials for accelerated approved cancer drugs violate equipoise?;Luri;J Clin Oncol, ASCO Proc,2006